Eversept Partners’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-545,330
Closed -$20.3M 142
2026
Q1
$21.8M Buy
+545,330
New +$25.8M 1.15% 25
2022
Q3
Sell
-179,093
Closed -$8.96M 83
2022
Q2
$8.96M Sell
179,093
-2,633
-1% -$128K 0.64% 38
2022
Q1
$9.44M Buy
181,726
+28,447
+19% +$1.47M 0.73% 39
2021
Q4
$9.03M Buy
153,279
+18,319
+14% +$1.05M 0.58% 46
2021
Q3
$7.4M Sell
134,960
-479,002
-78% -$26.7M 0.51% 49
2021
Q2
$31.5M Buy
613,962
+185,135
+43% +$9.56M 2.1% 18
2021
Q1
$22.1M Buy
428,827
+111,147
+35% +$6.11M 1.15% 25
2020
Q4
$17.8M Buy
317,680
+159,744
+101% +$8.52M 2.09% 18
2020
Q3
$8.75M Buy
157,936
+80,166
+103% +$4.16M 1.94% 17
2020
Q2
$3.53M Buy
+77,770
New +$3.48M 0.48% 34
2020
Q1
Sell
-129,199
Closed -$4.63M 75
2019
Q4
$4.63M Buy
+129,199
New +$4.8M 0.82% 33
2019
Q1
Sell
-52,151
Closed -$1.91M 61
2018
Q4
$1.91M Buy
+52,151
New +$1.94M 1.03% 21

Other funds holding QGEN

Eversept Partners's QGEN Position: Q2 2026 in Review

Eversept Partners sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 545,330 shares — an estimated $20.3M sold.

Eversept Partners first reported a position in QGEN in Q4 2018 and held it in 12 quarters. The position peaked at $31.5M in Q2 2021. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Eversept Partners reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
  • Eversept Partners sold 545,330 Qiagen shares in Q2 2026, an estimated $20.3M.
  • Eversept Partners first reported a position in Qiagen in Q4 2018 and held it in 12 quarters.
  • Eversept Partners's Qiagen position peaked at $31.5M in Q2 2021.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.